Abilify is manufactured by Otsuka America Pharmaceutical, Inc. and Bristol-Myers Squibb Company.
Abilify belongs to a group of medications called atypical (or second-generation)
antipsychotic medications. It is not entirely clear how this medication works for the treatment of schizophrenia,
bipolar disorder, autism, or major depression.
However, it is known to block or lessen the effects of several chemicals in the brain. These chemicals (such as dopamine and serotonin) may be elevated in people with schizophrenia or bipolar disorder (also known as
manic depression).